At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
解锁市场时间线与信号动态
最近 90 天内有 2,136 个信号。
该公司进入各个市场的顺序 — 从最早到最新
The Sequence podcast EP1: Inside the global genomics leader
The Sequence podcast EP1: Inside the global genomics leader
注册以查看完整信号动态
Illumina 的国际扩张与竞争对手的对比情况
条形图显示所对比公司之间的相对规模。
5 项指标| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
Illumina你 | 32 | 0 | -79% | 2.1k | 36 |
快速扩张——最近 90 天新增 146 个职位,较上一周期增长 56%。 以 Engineering 为主,集中在 新加坡。
Mexico · 昨天
CRM Senior Business Systems Analyst
Greater Bengaluru Area · 昨天
Staff PLM Ops Analyst
Singapore · 昨天
Logistics Coordinator 2
在技术栈中检测到 51 项技术。
覆盖 201 个市场 的 299 个进行中的广告系列。
进行中最近 90 天获 7 次提及。
因美纳在中国推出MiSeq i100 Series-CN,由本地制造基地生产,符合全球质量标准,支持科研、公共卫生及生物医药测序应用,提供更快交付与服务。
八月首个完整周将有来自AI、半导体、医疗保健、能源、消费、软件、金融科技、旅游和量子计算公司的重要财报,重点关注Palantir等市场重量级企业。
因美纳推出以DRAGEN驱动的移动式生信分析解决方案,将高性能算力直接送达科研与临床研究一线,解决数据本地化合规与部署效率挑战。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Illumina 的业务、市场和增长信号的快速解答。